Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.720
-0.018 (-2.38%)
At close: Mar 6, 2026, 4:00 PM EST
0.731
+0.010 (1.40%)
After-hours: Mar 6, 2026, 7:32 PM EST
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $23.09 million as of March 6, 2026. Its market cap has decreased by -75.69% in one year.
Market Cap
23.09M
Enterprise Value
-11.90M
1-Year Change
-75.69%
Ranking
Category
Stock Price
$0.72
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $23.09M, a decrease of -93.51%. That is a compound annual growth rate of -76.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 23.10M | -3.75% |
| Dec 31, 2025 | 24.00M | -72.06% |
| Dec 31, 2024 | 85.90M | -75.88% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Boundless Bio | 25.52M |
| FibroBiologics | 25.40M |
| Senti Biosciences | 25.04M |
| Neuphoria Therapeutics | 25.01M |
| Barinthus Biotherapeutics | 24.50M |
| Lixte Biotechnology Holdings | 24.48M |
| Marker Therapeutics | 24.01M |
| Vistagen Therapeutics | 23.97M |